Eli Lilly Sola Failure is a 'Serious Blow' to Biogen (BIIB) and Others in AD Field - Leerink
Go back to Eli Lilly Sola Failure is a 'Serious Blow' to Biogen (BIIB) and Others in AD Field - Leerink| BIOGEN IDEC Inc. (NASDAQ: BIIB) | Delayed: 217.81 +2.31 (1.07%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $215.50 | 52 Week High | $333.65 | |||
| Open | $216.14 | 52 Week Low | $223.02 | |||
| Day High | $218.72 | P/E | 27.89 | |||
| Day Low | $214.59 | EPS | $7.81 | |||
| Volume | 67,479 | |||||
| Lilly (Eli) & Co. (NYSE: LLY) | Delayed: 1163.50 +10.57 (0.92%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1152.93 | 52 Week High | $88.16 | |||
| Open | $1144.50 | 52 Week Low | $67.88 | |||
| Day High | $1165.00 | P/E | 269.33 | |||
| Day Low | $1134.41 | EPS | $4.32 | |||
| Volume | 438,423 | |||||
